Better Warnings About Link Between Vaping, THC And Lung Injury Risks Needed For Youths: Study

Teens who suffered vaping lung injuries were more likely to use THC containing products from illegal sources than adults who also suffered lung injuries, according to the findings of a new report which highlights the need for better warnings about problems associated with vaping and THC e-cigarette products.

Researchers with the U.S. Centers for Disease Control and Prevention (CDC) indicate in a new study that public health professionals should make a concerted effort to warn teens about the risk of EVALI (e-cigarette, or vaping, product use-associated lung injury) associated with products containing tetrahydrocannabinol (THC); especially if obtained from informal sources.

The findings were published in the journal JAMA Pediatrics, involving a cross-sectional study of more than 2,100 patients. They used national surveillance data obtained from the Centers for Disease Control and Prevention (CDC) during the 2019 e-cigarette, or vaping, product use-associated lung injury (EVALI) outbreak.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Researchers compared the differences between 360 hospitalized or deceased adolescents with EVALI, or vaping lung disease, to 859 young adults and 936 adults with EVALI.

According to their findings, teens with vaping lung disease were more likely than adults to report the use of illegally sourced e-cigarette or vaping products that contain THC. In addition, nearly 90% of teens who developed the vaping lung disease used THC containing e-cigarettes.

Furthermore, more than 96% of those teens said they got their THC vapes from illegal sources. About half said they obtained nicotine containing vapes from illegal or informal sources.

Comparatively, only about 75% of adults who developed vaping lung disease received their THC containing vapes from illegal sources and about 25% of adults got their nicotine containing e-cigarettes from informal sources.

Teens are also more likely to suffer from other health conditions, such as asthma or attention-deficit hyperactivity disorder (ADHD), which may also play a factor in their higher rate of lung injury, the researchers noted.

Younger users who suffered lung injuries were more than four times likely to have ADHD, the CDC researchers found. This may suggest some teens are attempting to self-medicate certain symptoms they may experience, leading them to informal sources of nicotine and THC that may contain harmful ingredients.

Among teens who contracted EVALI, researchers also found they were more likely to have asthma, gastrointestinal and constitutional symptoms than adults who contracted the disease.

Vaping Lung Injury Outbreak

The EVALI outbreak began in mid-2019 when doctors began reporting seeing patients, often young, with serious lung illness or injury after using vapes. Ultimately, the outbreak resulted in at least 3,000 hospitalizations and more than 60 deaths before the CDC stopped officially tracking the problem in February.

As investigations continued, and thousands of people became sick, officials determined THC-containing e-cigarettes were one primary source of the illness. Another source pointed to both tobacco and THC containing vapes which also contained vitamin E acetate as an additive.

More recently, as the coronavirus pandemic worsened and included patients experiencing respiratory symptoms, some patients who have the vaping lung disease are being mistakenly diagnosed with COVID-19.

“Public health and clinical professionals should continue to provide information to adolescents about the association between EVALI and THC-containing e-cigarette or vaping product use, especially those products obtained through informal sources, and that the use of any e-cigarette or vaping product is unsafe,” the CDC researchers concluded. “Compared with adults, it appears that adolescents with EVALI more frequently have a history of asthma and mental, emotional, or behavioral disorders, such as attention-deficit/hyperactivity disorder, and report nonspecific problems, including gastrointestinal and constitutional symptoms; therefore, obtaining a confidential substance use history that includes e-cigarette or vaping product use is recommended.”

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawsuit Alleges Suboxone Caused Dental Damage, Erosion and Tooth Decay
Lawsuit Alleges Suboxone Caused Dental Damage, Erosion and Tooth Decay (Posted yesterday)

Kentucky man has filed a lawsuit against Suboxone manufacturers, indicating the opioid treatment film strips were known for years to cause the kind of permanent tooth damage he suffered, long before warning labels were added by the drug manufacturer.

Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL
Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL (Posted 4 days ago)

Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit
Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit (Posted 5 days ago)

California woman indicates she was unaware there was a link between her meningioma and Depo-Provera injections until a study was published in March 2024, resulting in widespread publicity about the brain tumor risks.